SCHEMBL28809281

SCHEMBL28809281

CC(C)(C)OC(=O)NC1CCN(C(=O)OCc2ccccc2)CC1OC(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.47
▸ BCHE P06276 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ ATM Q13315 1/20 0.41
▸ NT5E P21589 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PLCG1 P19174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30161850 1.00 PDE4B (0.47) PDE4BBCHETDP1HTTATM
SCHEMBL2348371 0.94 BCHE (0.44) PDE4BBCHETDP1HTTATM
SCHEMBL30161883 0.94 PDE4B (0.48) PDE4BBCHETDP1HTTATM
SCHEMBL2348366 0.94 BCHE (0.44) PDE4BBCHETDP1HTTATM
SCHEMBL28809883 0.94 PDE4B (0.48) PDE4BBCHETDP1HTTATM
SCHEMBL31200717 0.91 PDE4B (0.50) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL20549043 0.87 BCHE (0.45) PDE4BBCHETDP1ATMNT5E
SCHEMBL19063875 0.87 BCHE (0.45) PDE4BBCHETDP1ATMNT5E
SCHEMBL19063874 0.87 BCHE (0.45) PDE4BBCHETDP1ATMNT5E
SCHEMBL28528480 0.84 PDE4B (0.52) PDE4BHTTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867717-A Heteroaryl dihydropyrimidine derivatives and methods for treating hepatitis b infection 詹森药业有限公司 2022-08-05 — — CN disclosed
Send feedback